ATP-gated P2X 7 receptors (P2X 7 R) are unusual plasma membrane ion channels that have been extensively studied in immune cells. More recently, P2X 7 R have been described as potential cancer cell biomarkers. However, mechanistic links between P2X 7 R and cancer cell processes are unknown. Here, we show, in the highly aggressive human breast cancer cell line MDA-MB-435s, that P2X 7 receptor is highly expressed and fully functional. Its activation is responsible for the extension of neurite-like cellular prolongations, of the increase in cell migration by 35% and in cell invasion through extracellular matrix by 150%. The change in cancer cell morphology and the increased migration appeared to be due to the activation of Ca 2 þ -activated SK3 potassium channels. The enhanced invasion through the extracellular matrix was related to the increase of mature forms of cysteine cathepsins in the extracellular medium, which was independent of SK3 channel activity and not associated with cell death. Pharmacological targeting of P2X 7 R in vivo was crucial for cell invasiveness in a zebrafish model of metastases. Our results demonstrate a novel mechanistic link between P2X 7 R functionality in cancer cells and invasiveness, a key parameter in tumour growth and in the development of metastases. They also suggest a potential therapeutic role for the newly developed P2X 7 R antagonists.
Introduction
Breast cancer is the most common female cancer and the first cause of women death by cancer worldwide. Most cancer patients do not die because of local complications of their primary solid tumour growth, which are relatively well treated, but rather to the appearance of metastases. The development of metastases consists of a complex series of events accomplished by tumour cells after they acquire numerous abilities, one of which being the acquisition of an invasive potency. This mainly lies into an enhanced migration and the ability to digest the extracellular matrix (Gupta and Massague, 2006) . Cell migration involves dynamic cytoskeletal changes and is highly regulated by the intracellular concentration of calcium. Basement membranes underlying epithelial cells as well as extracellular matrices constitute barriers for transformed cells to invade subjacent stroma. Their proteolytical disruption, by extracellular proteases, allows tumour cells to progress to malignancy and metastasis. In the last decade, studies mainly focused on the involvement of matrix metalloproteinases in the neoplastic progression (Egeblad and Werb, 2002) , but recently, it appeared that cysteine cathepsins are highly upregulated in a wide variety of cancers, including breast cancer (Mohamed and Sloane, 2006) . Indeed elevated cathepsin B expression correlates with poor prognosis in breast cancer as in other cancers (Jedeszko and Sloane, 2004) and its activity has been shown to enhance breast cancer cells invasiveness in vitro (Gillet et al., 2009) . Cathepsins classical localization within intracellular lysosomes is found to be modified in tumours. They can be secreted both at their pro-and active forms by cancer cells (Frosch et al., 1999; Roshy et al., 2003) . However, the signalling pathway regulating their release and activation in the extracellular medium has to be clarified.
Adenosine 5 0 -triphosphate (ATP) is a well known source of free energy for cells and is found at high concentrations (5-10 mM) in intracellular compartments. In some physiological occasions, ATP can be released extracellularly in very high concentrations. This also happens in necrotic cell death and pathological conditions. ATP is secreted by cancer cells into their microenvironment at relatively high concentrations (Raffaghello et al., 2006) and is released in sites of tissues damage such as perilesional regions of cancers (Wang et al., 2004b) . Indeed, tumour sites are known to contain much higher concentrations of ATP than healthy tissues where it would normally be undetectable (Pellegatti et al., 2008) . Extracellular ATP acts as a signalling molecule by activating plasma membrane G protein-coupled P2Y receptors and/or ligand-gated ion channels P2X receptors (Burnstock, 2006) . Among the members of the P2X receptors family, the latest cloned P2X 7 receptors (P2X 7 R) (Rassendren et al., 1997) are very unique by different features, some of them are: (1) their sensitivity to ATP (North, 2002) , (2) their facilitation under successive or sustained applications of agonist (Hibell et al., 2000; Roger et al., 2008 Roger et al., , 2010a and (3) the appearance of a large, non-selective membrane pore after sustained stimulations with ATP (Pelegrin and Surprenant, 2006) . Recently, several tumours have been shown to express P2X 7 R at unusually high levels (Adinolfi et al., 2002; Zhang et al., 2004; Slater et al., 2004a, b; Wang et al., 2004a; Raffaghello et al., 2006; Deli et al., 2007; Solini et al., 2008) , however, their functionality and involvement in the physiology of cancer cells remain unclear. In some studies performed on breast and prostate cancers, it was suggested that P2X 7 R might be non-functional (Slater et al., 2004a, b) , but proposed to serve as an early marker for cancer (Slater et al., 2005) . In other cancers, P2X 7 R activity could be responsible for anti-apoptotic effects (Deli et al., 2007) , for sustaining cell growth (Raffaghello et al., 2006) or for the release of IL-6 by cancer cells (Solini et al., 2008) . On the contrary, it was proposed to induce apoptosis in normal cervical epithelial cells (Wang et al., 2004a) and that its expression was decreased in cervical cancers (Li et al., 2006) . Therefore, in this study, we investigated the expression, characterized the functionality of P2X 7 R in highly metastasizing breast cancer cells and tried to clarify their involvement in oncogenic properties.
Results

Human cancer cells express functional P2X 7 R
We first analyzed the mRNA expression of P2X 7 R in human non-cancerous and cancerous mammary cells ( Figure 1a) . Importantly, P2X 7 R were not expressed in non-cancerous mammary cells (MCF-10A, 184A1 and Human Mammary Epithelial Cell) whereas they were markedly expressed in highly invasive MDA-MB-435s cells. Many polymorphisms have been identified in the P2RX7 gene, some of them being responsible for important functional alterations and associated to many diseases (Cabrini et al., 2005; Shemon et al., 2006; Roger et al., 2010b) . We therefore performed P2X 7 R complementary DNA sequencing in MDA-MB-435s cells. We did not identify any particular polymorphism the receptor expressed in cancer cells corresponded to the full-length P2X 7 A splice variant. In accordance with results coming from RT-PCR, western blot experiments indicated that P2X 7 R proteins were only found in MDA-MB-435s cancer cells (Figure 1b ). Although these cancer cells mainly expressed P2X 7 R, low levels of mRNA for P2X 4 , P2X 5 and P2X 6 receptors were also detected ( Figure 1c ). As in cancer cells mRNA expression does not always correlate to the translation in functional proteins (Roger et al., 2007) , we performed patch clamp experiments to assess the functionality of such receptors. We conducted experiments using 10 mM ATP, which is supposed to activate all P2X receptors except P2X 7 R, but did not record any ATP-evoked current from cancer cells. Only millimolar concentrations of ATP were able to trigger the appearance of an inward and facilitating current (Figure 1d ). These are among the well-known specificities of P2X 7 R-evoked currents. Figure 1e shows representative inward currents that never desensitized, recorded from a representative cancer cell during an ATP dose-response protocol. This protocol was used to draw the ATP concentration-peak current relationship from MDA-MB-435s cancer cells. This was compared with the relationship coming from HEK293 cells expressing human P2X 7 R (hP2X 7 R) ( Figure 1d ). Fitting these relationships with sigmoidal equations gave ATP EC 50 of 3.3±0.2 mM and 3.4±0.7 mM for ATP-evoked currents coming from MDA-MB-435s and hP2X 7 R expressing HEK293 cells, respectively.
As shown in Figure 2a , multiple applications of 5 mM ATP to cancer cells were responsible for a dramatic increase of ATP-evoked currents. This property is a particularity of P2X 7 R and is called facilitation (Hibell et al., 2000; Roger et al., 2008 Roger et al., , 2010a . This led to a seven times increase of the current density from the first to the eighth ATP application (Figure 2b ). The use of the BzATP agonist gave us an EC 50 of 263±22 mM (Figure 2c ). This is in line with the fact that P2X 7 R are more sensitive to BzATP than to ATP (North, 2002) . ATP-evoked currents from MDA-MB-435s cancer cells were inhibited by human P2X 7 R antagonists KN62 and A740003 ( Figure 2d and supplementary Figure 1a ). Current inhibition curves indicated IC 50 of 16.3±2.1 nM (n ¼ 3-9 cells) and 9.8±0.9 nM (n ¼ 2-9 cells) for KN62 and A740003, respectively (Figure 2d ), which are the classical concentrations used for antagonizing hP2X 7 R activity (Donnelly-Roberts and Jarvis, 2007) . Sustained activation of P2X 7 R is also known to induce membrane permeation following the activation of pannexin-1 and allowing the uptake of membrane-impermeant fluorescent dyes such as ethidium (Pelegrin and Surprenant, 2006) . Ethidium uptake was also recorded in MDA-MB-435s cells stimulated with ATP (5mM), which was completely inhibited when KN62 (1 mM) was added to the external solution (Figure 2e ). Extracellular applications of ATP were responsible for the increase of the internal calcium concentration, monitored by Fluo-4 fluorescence. Although 5 mM ATP was responsible for a KN62-sensitive intracellular calcium rise, applying 10 mM ADP, UTP or ATP in the external solution was not able to increase the internal calcium (Figure 2f ), which is coherent with the fact that MDA-MB-435s cells only express P2Y 11 R among all metabotropic P2Y receptors, which are often coupled to a cyclic AMP signalling pathway (supplementary Figure 1B) . Taken together, all these results suggest that P2X 7 R are the only P2X receptors functional in MDA-MB-435s breast cancer cells.
P2X 7 R activation induces SK3-dependent changes in cell morphology and enhancement of cancer cell migration As exposed previously, several tumours have been shown to overexpress P2X 7 R; however, their participation in controlling cell proliferation or even apoptosis is not clear. As some studies proposed a role in apoptosis, we studied the survival of MDA-MB-435s cancer cells over 24 h under P2X 7 R stimulation (supplementary Figure 1C) . show the weak expression of mRNA for P2X 4 R, P2X 5 R and P2X 6 R, and a strong expression of P2X 7 R in the highly invasive MDA-MB-435s human breast cancer cell line. Positive controls of the primers were performed using corresponding human P2X receptor cDNA. (d) Whole-cell patch clamp recordings from MDA-MB-435s cancer cells. Membrane potential was held at À60 mV and whole-cell currents were recorded during ATP applications. Effect of 10-s long applications of 10 mM (left) and 5 mM (right) ATP on whole-cell currents. Although 10 mM ATP is not able to produce any current, 5 mM ATP is responsible for a facilitating P2X 7 R-like inward current. (e) Representative currents recorded from one MDA-MB-435s cell, in response to 10-s long applications of increasing concentrations of ATP (1, 3, 5 and 10 mM), after full facilitation. (f) ATP concentration-response curves for inward currents recorded after full facilitation. ATP-evoked currents, from 3-9 MDA-MB-435s cells (black circles) and from 2-9 HEK293 cells transfected with human P2X 7 R (gray squares), are expressed as a percentage of the maximum obtained with 10 mM ATP. The EC 50 obtained from sigmoidal fits were 3.3±0.2 mM in MDA-MB-435s cells (n ¼ 3-9 cells) and 3.4±0.7 mM (n ¼ 16 cells) in hP2X 7 R-HEK293 cells. Treating the cells in increasing concentrations of ATP, from 30 mM to 3 mM, had no significant effect on cell viability compared with a control condition without ATP. However, ATP concentrations higher than 3 mM induced a significant cell death, which was prevented by co-incubation with KN62 or A740003 (supplementary Figure 1C ). This indicated that P2X 7 R could be responsible for cancer cell death at very high, but not at lower activation levels and durations. In many cell types, the sustained activation of P2X 7 R also results in morphological events such as plasma membrane blebbing (Roger et al., 2008) or cell shrinkage with a loss of cell prolongations (Raffaghello et al., 2006) . In contrast, we found that activation of P2X 7 R in cancer cells caused Figure 2A) . These morphological changes observed in presence of extracellular ATP are the hallmarks of increased migratory abilities. This fact correlated with the formation of actin stress fibres under ATP stimulation ( Figure 3d ). Moreover, stimulating the cells with 1 and 3 mM ATP significantly increased cell migration by 13 and 32%, respectively ( Figure 4a ). P2X 7 R receptors antagonists KN62 and A740003 reduced cell migration by about 5% when applied alone and completely abolished the ATPmediated increase of cell migration. In cells transfected with siP2X 7 , ATP was not able to increase cell migration ( Figure 4b ). Recently, it has been shown that SK3 channels, from the family of small-conductance Ca 2 þ -activated potassium channels (SK Ca ), were important regulators of breast , colon (Potier et al., 2010) and melanoma (Chantome et al., 2009 ) cancer cells migration. We first verified that siRNA directed against mRNA for P2X 7 R did not interfere with SK3 protein expression (supplementary Figure 2B) . We hypothesized that the P2X 7 R-mediated calcium influx (Figure 2f ) could activate SK3 receptors and thereby enhance the change in cell morphology leading to the increase of cell migration. Indeed, we showed that ATP stimulation of cancer cells increased apamin-sensitive currents (Supplementary Figure 3 ). Then, we developed MDA-MB435s-derived cell lines transduced with lentiviral vectors expressing either an untargeted short hairpin RNA (shRdm) or a short hairpin RNA specific for the SK3 transcript (shSK3). The expression of SK3 and P2X 7 R proteins in these cell lines can be observed in Figure 5a . In shSK3 cancer cells, the stimulation with ATP did not induce the formation of cellular prolongations (Figure 5b ). Blocking SK Ca channels with apamin reduced cancer cell migration by about 50% in wild-type MDA-MB-435s cells (Figure 5c ). Very interestingly, ATP was no longer able to promote cell migration in presence of apamin, supporting the fact that the promigratory effect of P2X 7 R could be due to a potentiation of SK Ca channels activity. With the MDA-MB-435s shRdm cell line, we found the same effects of ATP and apamin on cell migration than with wild-type cells. In contrast, MDA-MB-435s shSK3 cell line exhibited a 50% reduction in basal cell migration, which was insensitive to ATP stimulation (Figure 5c ).
P2X 7 R enhances cysteine cathepsins-dependent cell invasiveness
The ability of cancer cells to invade and spread all over the body relies on their capacity to migrate, as studied above, but also on their capacity to degrade their surrounding extracellular matrix. Therefore, we studied the invasive properties of MDA-MB-435s cancer cell in relation with P2X 7 R stimulation, by using invasion inserts with filters coated with Matrigel (Becton Dickinson, Le Pont de Claix, France) which mimics the extracellular matrix. As shown on Figure 6a , whereas 0.1 mM ATP had no significant effect, 1 and 3 mM ATP massively increased cell invasion by 37 and 150%, respectively. This ATP-induced invasion increase was completely inhibited in the presence of KN62 and A740003. Similar results were obtained with the human lung cancer cell line A549 (See Supplementary Figure 4) . This effect of ATP was found in MDA-MB-435s cells transfected with siRNA-A as a control, but totally abolished in cells transfected with siP2X 7 (Figure 6b ) confirming results obtained with antagonists. Silencing P2X 7 R expression also resulted in a 24% reduction of basal cancer cell invasiveness in the absence of ATP stimulation. Interestingly, the use of the broad-spectrum Figure 5a) . As cathepsins seem to be the predominant proteases for MDA-MB-435s cells invasion, we investigated their activity towards the Z-Phe-Arg-AMC fluorogenic substrate in supernatants of cells incubated or not with ATP. In basal conditions, cell-free supernatants were responsible for a cathepsin activity, which was massively increased (45-fold increase) after cell stimulation for 24 h with 3 mM ATP (Figure 6d ). This effect was inhibited when cells were co-stimulated with KN62, while apamin had no effect. To confirm the specificity of cathepsin activity in supernatants, we pre-incubated samples coming from ATP-stimulated cells with the cathepsin inhibitor E64 and in that case fluorescence release was almost inexistent (Figure 6d ). Among all members of cysteine cathepsins, the cathepsin B has been involved in the progression of different cancers (Mohamed and Sloane, 2006) . Cathepsin B was immunodetected under its inactive proform (46 kDa) and two active forms, the single-(31 kDa) and double-chain (24-25 kDa) forms (Figure 6e ). Whereas, ATP stimulation did not modify the concentration of internal forms (pro-cathepsin B is better seen with longer exposition time in cell lysates, see Supplementary Figure 5B ), it was responsible for the specific increase of active forms of cathepsin B in supernatants concomitantly with a reduction of the proform amount. This effect was inhibited in presence of KN62 whereas apamin had no effect on ATP-induced cathepsin B release and activation in supernatants (Figure 6e ). Relative amounts of pro-and active forms of cathepsins B, L, H, S and K were assessed from western blot experiments coming from cells stimulated with ATP (Figure 5f , Supplementary Figure 4C ). ATP treatment was responsible for 1.5-to 5.5-fold increases of active forms of all cathepsins in supernatants (Figure 6f ). In contrast, ATP induced a significant reduction of proforms for cathepsins B and L. Differentially it was responsible for an increase of pro-cathepsins S and K.
P2X 7 R activity is required for in vivo MDA-MB-435s invasiveness We finally analyzed the in vivo relevance of P2X 7 R function on MDA-MB-435s metastases, taking advantage of the zebrafish as a model to study the invasive and metastatic behaviour of human tumour cells (Marques et al., 2009) . First, we validated this model by comparing the ability of highly invasive MDA-MB-435s cells with Same invasion experiments were performed on MDA-MB-435s cancer cells transfected with siRNA directed against P2RX7 mRNA (siP2X7) or scramble siRNA-A as a control (siCTL), in control condition (no ATP), or in presence of 3 mM ATP with or without 1 mM KN62 (n ¼ 3 independent experiments). (c) Relative wild-type MDA-MB-435s cell invasion through Matrigel-coated inserts, in presence or not the broad-spectrum cysteine cathepsin inhibitor E-64 (100 mM) in presence or not of 3 mM ATP (n ¼ 4 independent experiments). (d) Enzymatic assay performed on cell-free concentrated supernatants (in sodium-acetate buffer pH5.5, containing 2mM dithiothreitol, and 2mM EDTA) in the presence of the fluorogenic substrate Z-Phe-Arg-AMC (40 mM) specific for cystein cathepsins after incubating cells for 24 h with ATP (3 mM) in presence or not of 1 mM KN62 or 1 nM Apamin (Apa). Specificity of the cystein cathepsin-dependent substrate hydrolysis was checked by preincubating the sample from ATP-stimulated condition with E64 (100 mM) (n ¼ 3 independent experiments). (e) Western blot analyses for cathepsin B in wild-type MDA-MB-435s cells lysates or concentrated cell-free supernatants after 24 h treatment with ATP (3 mM) in presence or not of KN62 (1 mM) and Apamin (1 nM). Different forms of cathepsin B are detected: the proform (46 kDa, white arrow) and the two active forms, single-chain (31 kDa, SC) and double chain (24-25 kDa, DC) indicated by black arrows. (f) Relative amounts of proforms (Pro) and active forms of cathepsins B, L, H, S and K in supernatants of wild-type cells stimulated for 24 h treatment with ATP (3 mM). Amounts of cathepsins were calculated from densitometric analyses from western-blots experiments using the software Quantity One (Bio-Rad) and expressed as a proportion of the control condition without ATP. Statistics were done using a Mann-Whitney rank sum test. Statistically different from control condition at *Po0.05; **Po0.01. ***Po0.001.
poorly invasive EO33 oesophagus adenocarcinoma cell line to escape the yolk sac of zebrafish embryos. In total, 46.4% of the zebrafish embryos injected with MDA-MB-435s cells presented more than three cells outside of the yolk sac 48 h after injection, whereas only 25.9% of the embryos presented metastases after injection of EO33 cells (Figure 7a ). These differences in metastases correlated with P2X 7 R expression levels, MDA-MB-435s cells expressed almost 200 more times P2X 7 R transcript than EO33 cells (Figure 7b ). Treatment with selective P2X 7 R antagonist A-438079 was able to significantly reduce the number of zebrafish embryos with metastases after injection of MDA-MB-435s cells (Figures 7a and c) , but did not affect the invasive in vivo behaviour of EO33 cells (Figure 7a ).
Discussion
P2X 7 R is an intriguing receptor from which pharmacological activation is generally associated to cytotoxic effects (Surprenant et al., 1996; Di Virgilio et al., 1998) therefore leading to the hypothesis that their overexpression or stimulation could be deleterious for cells. Surprisingly, it was found that P2X 7 R is expressed at very high levels in several tumours, compared with Deli et al., 2007; Solini et al., 2008) and was even proposed to represent an early cancer marker (Slater et al., 2005) . In fact, among all cancer types tested, cervical cancer is the only exception to our knowledge with a decreased expression of P2X 7 R in cancer cells (Li et al., 2006) . Contrarily to initial assumptions, P2X 7 R were reported to have anti-apoptotic effects (Deli et al., 2007) and even to promote cell growth (Adinolfi et al., 2005; Raffaghello et al., 2006; Di Virgilio et al., 2009) in some cancer cells. All these studies mainly focused on the regulation of cell proliferation/apoptosis and other important parameters such as cancer cell invasiveness were not assessed.
In this study, we showed, for the first time to our knowledge, the expression and full characterisation of functional ATP-gated P2X 7 R in highly invasive breast cancer cells (P2X 7 R-current, Ca 2 þ influx and dye uptake). We showed that very high concentrations of ATP (43 mM) could be responsible for mild P2X 7 Rdependent cell death, but more importantly that smaller concentrations still activating P2X 7 R (1-3 mM), were responsible for morphological changes leading to the acquisition of a pro-migratory phenotype and no membrane blebbing. The formation of cellular prolongations and cell migration were found to be dramatically potentiated under P2X 7 R stimulation through the activation of Ca 2 þ -activated potassium channels SK3. This activation of SK3 channels is most probably resulting from the increase of the internal calcium concentration. We also investigated the regulation of invasive properties, which are taking into account the proteolytic disruption of the extracellular matrix. Our results indicated that P2X 7 R activation enhanced cancer cell invasiveness in vitro and in vivo, through the increase of active forms of external proteases.
Most dramatic results on cellular extension, cell migration and invasiveness were obtained after P2X 7 R stimulation with millimolar concentrations of extracellular ATP. These very high concentrations of external ATP are known to occur in tumours, particularly at the vicinity of necrotic areas (Raffaghello et al., 2006; Wang et al., 2004b) , whereas it is undetectable in normal tissues (Pellegatti et al., 2008) . However, the use of antagonists (KN62 or A740003) or siP2X 7 R in basal conditions, without applying ATP, were responsible for small reductions of these three parameters. These results raise the possibility of a constitutive activity of P2X 7 R in cancer cells. One possible explanation for this could be the tonic release of ATP by cancer cells responsible for autocrine/paracrine regulations. Indeed, P2X 7 R have already been demonstrated to be responsible for trophic activities on different cell types, including cancer cells, in the absence of ATP stimulation (Adinolfi et al., 2005 (Adinolfi et al., , 2010 Di Virgilio et al., 2009) . Alternatively, one other hypothesis could be a basal, channel-independent, activity of the receptor in the complete absence of any purinergic stimulation. This aspect will have to be further clarified.
Although there are five catalytic types (aspartic, cysteine, metallo, serine and threonine) of proteases that can degrade the extracellular matrix, we showed that the basal as well as the P2X 7 R-dependent invasiveness of MDA-MB-435s cells were mainly due to the activity of cysteine cathepsins. Cathepsins were initially characterized as specific lysosomal markers, and the release of mature forms in the extracellular compartment was observed from epithelial cells (Rodriguez et al., 1997) as well as immune cells (Lopez-Castejon et al., 2010) and proposed to be mainly due to lysosomal exocytosis. These proteases are often upregulated in various human cancers including breast cancer and are implicated in numerous tumourigenic processes, such as invasion and metastasis (Mohamed and Sloane, 2006) . They are known to be extracellularly active, even if the events leading to their extracellular secretion or activation are not well understood. Importantly, we confirm in this study that high amounts of immature forms of cathepsins are tonically released by cancer cells at much higher contents than active forms, which as already been reported (Roshy et al., 2003; Gillet et al., 2009) . These cathepsins might be constitutively extruded from cellular compartments different from lysosomes, from which it is expected to only find active forms. We showed that stimulating P2X 7 R in cancer cells led to the increase of mature forms of all cysteine cathepsins tested and to the increase of matrix invasion. This phenomenon seemed to be completely independent on the SK3 channels activation and might represent a P2X 7 R-dependent inducible secretion/or activation pathway. We can observe that cathepsins S and K proforms and active forms were increased upon P2X 7 R activity. In contrast, only cathepsins B and L mature forms were increased, concomitantly to the reduction of proforms, after ATP stimulation. Indeed, we can hypothesize that there are two different pools of P2X 7 R-regulated cathepsins. Although the first pool of proteases (containing cathepsins S and K) could come from a P2X 7 Rregulated release pathway, the second pool of cathepsins (B and L) could be extracellularly matured. One possible explanation is the P2X 7 R-dependent activation or release of a protease that cleaves pro-forms of cathepsins B and L into active forms in the extracellular space.
Interestingly, the expression of other ion channels have been shown to be deregulated in cancer compared with non-cancer cells, among them are voltage-gated sodium channels . These channels have also been demonstrated to enhance the cysteine cathepsin-dependent invasiveness of breast cancer cells through the sodium influx (Gillet et al., 2009) . P2X 7 R being non-specific cation-permeant channels, this raises the question of a possible involvement of internal sodium in the regulation of cathepsins activity/release and in the invasiveness of cancer cells.
In addition, we used the zebrafish model to study the in vivo invasive properties of MDA-MB-435s cancer cells (Marques et al., 2009) . Pharmacologically targeting of P2X 7 R with selective inhibitor A-438079 decreased the metastases rate of MDA-MB-435s cells from the yolk sac of zebrafish embryos, but did not altered metastases rate of a non-expressing P2X 7 R cancer cell line, confirming the in vivo involvement of P2X 7 R in the invasiveness properties of MDA-MB-435s.
In conclusion, we have shown a new oncogenic role for P2X 7 R in the migration and cathepsin-dependent invasiveness of cancer cells. These phenomenon are critical for cancer cell spreading in tissues and therefore to the development of metastases. As such, P2X 7 R could be considered as an important invasiveness promoter and might represent a new target for anti-metastatic agents.
Materials and methods
Cells and culture
Human MDA-MB-435s breast cancer cells and EO33 oesophageal adenocarcinoma cells were maintained in Dulbecco's modified Eagle's medium, supplemented with 5% foetal calf serum. The immortalized normal mammary epithelial cell lines MCF-10A and 184A1 were cultured in Dulbecco's modified Eagle's medium/Ham's F-12, 1:1 mix containing 5% horse serum (Invitrogen, Illkirch, France), insulin (10 mg/ml), epidermal growth factor (20 ng/ml), hydrocortisone (0.5 mg/ml), and, for MCF-10A and 184A1, 100 ng/ml cholera toxin and 1 ng/ml cholera toxin plus 5 mg/ml transferrin, respectively. Cell lines were from the American Type Culture Collection (LGC Promochem, Molsheim, France). Human Mammary Epithelial Cells are long-term primary culture of noncancerous mammary epithelial cells, maintained in an adapted mammary epithelial growth medium (MEGM Bullet kit, Cambrex, East Rutherford, NJ, USA). Human Embryonic Kidney (HEK293) cells were maintained in Dulbecco's modified Eagle's: F12 medium, supplemented with 10% heat-inactivated foetal calf serum and 2 mM L-glutamine. All cell types were grown at 37 1C in a humidified 5% CO 2 incubator.
Zebrafish maintenance and in vivo zebrafish metastatic assays Zebrafish (Danio rerio) AB, from the Zebrafish International Resource Centre, was maintained in re-circulating tanks according to standard procedures ('The zebrafish handbook: a laboratory use of zebrafish, Brachydanio rerio'). Adult fish were maintained at 261C, with a light/dark cycle of 14/10 h and were fed twice daily, once with dry flake food (PRODAC, Malaga, Spain) and once with live arthemia (MC 450, IVE AQUACULTURE, INVE Aquaculture, Vigo, Spain). Zebrafish embryos were maintained in egg water at 28.51C, fed during 5 days with NOVO TOM and with live arthemia at 11 days of life. The experiments performed comply with the Guidelines of the European Union Council for animal experimentation (86/609/EU) and were approved by the Bioethical Committee of the University Hospital Virgen de la Arrixaca.
MDA-MB-435s or EO33 cells were trypsinized, washed and stained with the vital cell tracker red fluorescent CM-Dil (Vibrant, Invitrogen). Labelled cells were incubated for 30 min with 10 mM of the specific P2X 7 R antagonist A-438079 (Tocris, Bristol, UK) or vehicle (DMSO), centrifuged, resuspended in 67% of DPBS, 5 fetal calf serum, 0.05% Phenol Red and injected into the yolk sac of dechorionated zebrafish embryos using the method described in Marques et al., 2009 . Briefly 100-150 labelled cells in 4 nl were injected into the yolk sac of zebrafish embryos using a manual injector (Narishige, East Meadow (Long Island), NY, USA). Fish with fluorescent cells outside the implantation area at 2 h were excluded from further analysis. All other fish were incubated at 351C for 48 h and analyzed with a SteReo Lumar.V12 stereomicrsocope with an AxioCam MR5 camera (Carl Zeiss, Thornwood, NY, USA). Evaluation criteria for invasion were that at least three cells had to be identified outside of the yolk. Injection of A-438079 or DMSO vehicle into the yolk sac of zebrafish embryos did not affect the development of the fish and did not affect the viability of MDA-MB-435s or EO33 cells.
Small interfering RNA transfection and small hairpin RNA MDA-MB-435s breast cancer cells were transfected with siRNA directed against P2RX7 mRNA (siP2X7) or scramble siRNA-A as a control which were purchased from Tebu-Bio (Le Perray en Yvelines, France). Cells were transfected with 20 nM siRNA by using Lipofectamine RNAi max (Invitrogen). Experiments were performed 24 h after transfection.
To inhibit SK3 channel expression, we constructed a lentiviral vector encoding a short hairpin RNA (shRNA) specifically targeting the human KCa2.3 gene as using the same protocol than already reported, but adapted to breast cancer cells (Chantome et al., 2009) . Briefly, the sequence encoding shSK3 was obtained by PCR elongation of two partially complementary primers; this also allowed us to introduce two restriction enzyme sites to facilitate manipulations. Forward primer: shSK3-BamH I 5 0 -ggATCCCCCCATTCCTggCgAgT ACAATTCAAgAgATT-3 0 ; shSK3-Hind III 5 0 -AAgCTTA AAAACCATTCCTggCgAgTACAATCTCTTgAATT-3 0 , as a reverse primer. The underscored sequences are complementary. For control experiments, following the same protocol as above, we constructed a lentiviral vector expressing an untargeted shRNA (pLenti-shRdm). For this, we used the following primers, shRD1_S: 5 0 -ggATCCCCgCCgACCAAT TCACggCCgTTCAAgAgACg-3 0 and shRD1_AS: 5 0 -AAgCT TAAAAAgCCgACCAATTCACggCCgTCTCTTgAACg-3 0 . These experiments resulted in two cell lines: MDA-MB-435s shSK3 and MDA-MB-435s shRdm.
Electrophysiological recording
Electrophysiological recordings were performed in the whole cell configuration of the patch clamp technique as already reported (Roger et al., 2008) . Patch pipettes were pulled from borosilicate glass (WPI, Stevenage, UK) to a resistance of 4-6 MO. Currents were recorded under voltage-clamp mode using a MultiClamp 700A patch clamp amplifier (Axon Instrument, Foster City, CA, USA) and analogical signals were filtered at 10 kHz and digitized using a 1322A Digidata converter. Cell capacitance and series resistances were electronically compensated. Membrane potential was held at À60 mV. Experiments were performed at room temperature (20-25 1C) in a standard external physiological saline solution (PSS) and pipettes were filled with different intracellular solutions (see Solutions). Agonists (Adenosine 5 0 -triphosphate, ATP; or 2 0 ,3 0 -0-(benzoyl-4-benzoyl)-ATP, Bz-ATP) were externally applied using a RSC200 fast-flow delivery system (BioLogic Science Instruments, Claix, France) for 10 s, at the concentration indicated in Figure legends . For the facilitation protocol, numerous 10-s long applications of 5 mM ATP were performed, separated by 40-s intervals in normal PSS. Human P2X 7 R antagonists (KN62 and A740003) were perifused into the bath for 2 min before recording their effect in presence of 5 mM ATP. Concentration-response curves to agonists were realized by first obtaining a maximum response to 10 mM agonist and then by applying decreasing concentrations of agonist, before or after full P2X receptors facilitation (as indicated in Figure Legends) . Concentration-responses curves were plotted using Origin Microcal 6.0 software (Microcal Software Inc., Northampton, MA, USA) and EC 50 were defined using the Sigmoidal equation provided by this software. Current amplitudes were normalized to cell capacitances and expressed as current densities (pA/pF).
Solutions
The external PSS had the following composition (in mM): 147 NaCl, 10 N-2-hydroxyethylpiperazine-N 0 -2ethansulphonic acid (HEPES), 13 D-Glucose, 2 KCl, 2 CaCl 2 and 1 MgCl 2 . Agonist and antagonist solutions were prepared in PSS at the concentrations indicated in the figure legends. The intracellular solution had the following composition (in mM): 147 NaCl, 10 HEPES and 10 ethylene glycol-bis-(2-aminoethyl ether)-N, N, N 0 , N 0 -tetraacetic acid (EGTA). Osmolarity and pH values were 295-315 mOsm and 7.3, respectively. The loading buffer for Fluo-4AM calcium measurements had the following composition (in mM): 136 NaCl, 1.8 KCl, 1.2 KH 2 PO 4 , 5 NaHCO 3 , 2 CaCl 2 and 1.2 MgSO 4 , 20 HEPES, 6 D-Glucose and 5 EGTA.
Reverse transcription PCR (RT-PCR) and quantitative RT-PCR analysis
Reverse transcription PCR experiments were done according to standard protocols. Total RNA extractions from MDA-MB-435s were performed using RNeasy Mini kit (Qiagen, Courtaboeuf, France), followed by reverse transcription using SUPERSCRIPT III (Invitrogen) RNAse H-reverse transcriptase with oligo-dT. Specific primers for human P2X 1-7 and P2Y receptors were used in PCR (see Table 1 ). The efficacy of these primers was checked with corresponding hP2X/hP2Y receptor complementary DNA in pcDNA3.1 plasmids (Supplementary Figure 1a , bottom panel and supplementary Figure 2b , bottom panel). The temperature profile for PCR was 1 min at 94 1C followed by amplification for 30 cycles which consisted of 30 s at 94 1C, 30 s at 55 1C and 1 min at 72 1C and a final extension for 5 min at 72 1C. PCR products were then analyzed by electrophoresis in 1% agarose gel containing ethidium bromide, and visualized by UV transillumination. Detailed methods used for qRT-PCR have been described previously (Pelegrin and Surprenant, 2006) . Specific primers were purchased from Qiagen (QuantiTech Primer Assays), for each primer set the efficiency was 495% and a single product was seen on melt curve analysis. Relative gene expression levels were calculated using the 2 -DDCt method normalizing to GAPDH expression levels and the fold differences in expression was relative to HEK293 cells expression level.
Western blotting
Western blot experiments for cystein cathepsins detection were performed on MDA-MB-435s cell lysates and concentrated supernatants. Cells were grown to 80% confluence in a six-well plate. After 24 h treatment (ATP or/and antagonists) in Optimem medium (Invitrogen), cell supernatants were taken and concentrated using 10 000 MWCO filters (Millipore, Billireca, MA, USA). Cells were washed twice in phosphatebuffered saline then lysed in RIPA buffer (20 mM Tris-HCl pH7.4, 150 mM NaCl, 1 mM MgCl 2 and 1 mM CaCl 2 ) with 1% Triton X-100 and supplemented complete protease inhibitor cocktail (Roche, Welwyn Garden City, UK) for 1 h at 4 1C. Cell lysates were then centrifuged at 16,000 g for 10 min to pellet debris. Total protein samples were removed and assayed for protein content using the Bio-Rad Protein Assay kit (Bio-Rad, Bath, UK). Sodium dodecyl sulphate-polyacrylamide gel electrophoresis sample buffer was added and the samples were boiled for 4 min at 100 1C. Samples were loaded (5 mg of total proteins for cell lysates and 6 ml of concentrated supernatants) and electrophoretically separated on 12% polyacrylamide gels and then transferred to polyvinylidene difluoride membranes.
Western blotting was performed to standard protocols and cathepsin proteins were visualized using polyclonal rabbit antihuman cathepsin B primary antibodies (1/1,000, Fitzgerald, North Acton, MA, USA), polyclonal rabbit anti-human cathepsin S primary antibodies (1/5,000, Calbiochem, Nottingham, UK), polyclonal rabbit anti-human cathepsin L primary antibodies (1/2,000, Calbiochem), polyclonal rabbit anti-human cathepsin K primary antibodies (1/2,000, Calbiochem) and a goat anti-rabbit horseradish peroxidase (HRP)-conjugated secondary antibody (1/5,000). To study SK3 and P2X 7 R proteins, 40 mg of total proteins were loaded then analysed using rabbit polyclonal anti-SK3 channels (1/250, SigmaAldrich, L'Isle d'Abeau, France) or a rabbit polyclonal anti-P2X7 antibody (1/200, Alomone, Jerusalem, Israel) then secondary goat anti-rabbit-HRP-conjugated antibodies (1/1,000, Tebu-Bio). b-actin, GAPDH and HSC70 proteins were used for loading control experiments and were immunodetected using anti-b-actin-HRP conjugated (1/1,000, Tebu-Bio), mouse anti-GAPDH (1/2,000, Sigma-Aldrich) and mouse P2RX1  TTTCATCGTGACCCCGAAGCAG  TCAAAGCGAATCCCAAACACC  633  P2RX2  ACCTGCCCCGAGAGCATAAG  AATGACCCCGATGACACCACCC  426  P2RX3  CACCTCGGTCTTTGTCATCATCAC  TGTTGAACTTGCCAGCATTCC  695  P2RX4  ACAGCAACGGAGTCTCAACAGG  CCTTCCCAAACACAATGATGTCG  561  P2RX5  AACCTGATTGTGACCCCCAACC  TCGCAGAAGAAAGCACCCTTGC  683  P2RX6  GGTGACCAACTTCCTTGTGACG  CCCAGTGAACTCTGATGCCTACAG  476  P2RX7  TGCGATGGACTTCACAGATTTG  TGCCCTTCACTCTTCGGAAAC  465  P2Y1R  CCGGCTGTCTACATCTTGGT  GGCAGAGTCAGCACGTACAA  152  P2Y2R  CCACCTGCCTTCTCACTAGC  TGGGAAATCTCAAGGACTGG  163  P2Y4R  TGCCTGGTCACTCTTGTTTG  GTACTCGGCAGTCAGCTTCC  205  P2Y6R  CGACCACATGAGCTCCTACA  GAGCTTCTGGGTCCTGTGAG  198  P2Y11R  AGGGCAAAGTGATGTTCCAC  CCCTCCAGGCTCTTCTTTCT  175  P2Y12R  AACTGGGAACAGGACCACTG  ACATGAATGCCCAGATGACA  201  P2Y13R  TCGTGGCTGTCTTCTTTGTG  TTTCTTGGCTTGATGCTGTG  249  P2Y14R  TTAAAAGGCCTCTGCCTTCA  AGAGCTGGGCACGTAAAAGA  190 P2X 7 R increases cancer cell invasiveness B Jelassi et al anti-HSC70 (1/30,000 Tebu-Bio), respectively. Protein detection was done using the electrochemiluminescence (ECL)-plus kit (Amersham, Pantin, France) and Kodak Bio-Mark MS films (Sigma-Aldrich).
Fluo-4AM and ethidium uptake assays Changes in free internal calcium concentration were measured with the fluorescent indicator Fluo-4AM. A Nikon confocal microscope with Fluar x20 objective (Nikon, Kingston upon Thames, UK) was used. Cells plated onto 13 mm coverslips were loaded for 30 min at 37 1C with 1 mM Fluo-4AM and 0.02% pluronic acid in a loading buffer (see Solutions). Excess dye was removed by rinsing the cells twice with PSS. Cells were then incubated for an additional 10 min in PSS. Cells were superfused (2 ml/min) at concentrations indicated in figure legends. Images were acquired at 4 s intervals; numerous cells in a field of view were measured for 800 s and averaged from three separate experiments to obtain the mean Fluo-4 fluorescent signal. To measure ethidium uptake, ethidium bromide (25 mM) was added to superfusion solutions. Images were acquired at 6 s intervals for 900 s.
Cell survival and morphology
To assess the cell survival, 2 Â 10 5 cells were seeded per well in six-well plates in a control culture medium or in presence of different concentrations of ATP/inhibitors, and were grown for 24 h. Cell numbers were assayed by the tetrazolium salt assay as previously described (Gillet et al., 2009) . Cell survival was expressed as formazan 492 nm absorbance and expressed as a ratio by comparison with the control condition, in the absence of drug or ATP (on the same day of the experiment). Results were validated by manual cell counting. Three independent experiments were performed. The analysis of cell morphology was done using the ImageJ software 1.38I (National Institutes of Health, Bethesda, MD, USA). They were considered as 'cellular extensions' and counted only cell projections showing a size bigger than the cell body.
Cell migration and cell invasiveness assays Cell migration was analyzed, in 24-well plates receiving 8 mM pore size polyethylene terephtalate membrane cell culture inserts (VWR International, Leuven, Belgium). The upper compartment was seeded with 2 Â 10 4 viable cells in their basal culture medium. The lower compartment was filled with their culture medium supplemented with 10% fetal calf serum, instead of 5%, as a chemoattractant. After 24 h at 37 1C, cells that had migrated and were attached to the lower side were stained with haematoxylin and counted, using a light microscope. Cell invasiveness was assessed using the same inserts as above, but with the membrane covered with a film of Matrigel (Collaborative Research, Le Pont de Claix, France). In that case, 4 Â 10 4 viable cells were seeded in the upper compartment. Cell migration and invasiveness assays were performed in triplicates in 3-8 separate experiments. For easier comparison, results obtained for migration and invasion were normalized to the control condition in absence of drug or ATP.
Confocal microscopy MDA-MB-435s cells were cultured on glass coverslips covered with a film of Matrigel (Becton Dickinson) for 24 h then treated with 3 mM ATP in Dulbecco's modified Eagle's medium containing 5% fetal calf serum for 24 h. Cells were then fixed for 10 min in 4% paraformaldehyde and permeabilized by incubation for 15 min in 0.1% triton-X-100 in phosphate-buffered saline at room temperature. Unspecific sites were saturated by incubating for 30 min with 3% bovine serum albumin and 3% normal goat serum in phosphate-buffered saline. F-actin was stained by incubating the cells for 60 min with Alexa Fluor 594 phalloidin (1/200, Invitrogen). Confocal microscopy was performed with an Olympus Fluoview 500 microscope (Olympus, Southend-onSea, UK).
Cysteine cathepsin activity assays Supernatants of MDA-MB-435s cancer cells incubated for 24 h in the presence of ATP and/or other drugs were concentrated as described above. The fluorogenic substrate Z-Phe-Arg-AMC (Z standing for benzyloxycarbonyl and AMC for 7-amino-4-methyl coumarine, 40 mM) was used to measure proteolytic activities of cysteine cathepsin enzymes. The activation buffer for cysteine cathepsins was 0.1 M sodium acetate buffer pH5.5, containing 2 mM EDTA and 2 mM dithiothreitol. After activation in the assay buffer for 5 min, kinetic measurements were continuously recorded with the microtiterplate reader at 30 1C with l exc ¼ 335±60 nm and l em ¼ 460 ± 35 nm (Packard Instrument company, Meriden, CT, USA). Specificity of the cysteine cathepsindependent hydrolysis was verified by preincubating the samples with E64 (L-3-carboxy-trans-2, 3-epoxy-propionylleucylamide-(4-guanido)-butane, 100 mM).
Data analysis and statistics
Average results are expressed as the mean±s.e.m. from the number of cells or essays indicated in the figure legends. Statistical analyses, were performed using SigmaStat 3.0.1a (Systat software Inc., Chicago, IL, USA), were made using Student's t-tests. Alternatively, Mann-Whitney rank sum tests were used when the variance homogeneity test failed. Statistical significance is indicated as: *Po0.05; **Po0.01 and ***Po0.001.
